GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Preferred Dividends

BioGend Therapeutics Co (ROCO:6733) Preferred Dividends : NT$0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. BioGend Therapeutics Co's preferred dividends for the three months ended in Mar. 2024 was NT$0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0.0 Mil.

BioGend Therapeutics Co Preferred Dividends Historical Data

The historical data trend for BioGend Therapeutics Co's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co Preferred Dividends Chart

BioGend Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Preferred Dividends
Get a 7-Day Free Trial - - - - -

BioGend Therapeutics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioGend Therapeutics Co Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

BioGend Therapeutics Co  (ROCO:6733) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGend Therapeutics Co (ROCO:6733) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Preferred Dividends
Comparable Companies
ROCO:6794 TPE:1762 ROCO:8279 ROCO:6634 ROCO:1777 ROCO:4169 ROCO:6461 ROCO:6492 ROCO:6945 ROCO:6704 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
4th Floor, Number 3, Park Street, Nangang District, Taipei, TWN, 115
Website
https://www.biogend.com.tw
BioGend Therapeutics Co Ltd is a Taiwan based company involved in developing regenerative bio-orthopaedic medicine to advance the clinical science of maintaining healthy joints in skeletal system. The Company is primarily engaged in the research and development of bone medical device related products. Its products under development include Big-001, Big-006 and Big-009.

BioGend Therapeutics Co (ROCO:6733) Headlines

No Headlines